Moksh Shah
Vadodara, GJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Benzothiazole-Based Anti-Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025.
Journal: Chemical record (New York, N.Y.)
Published: December 22, 2025
Exploring imidazo[1,2-a]pyridine hybrids in cancer therapy: ADMET profiling, molecular docking, MD simulations and DFT calculations.
Journal: Scientific reports
Published: October 07, 2025
Design, synthesis and antitubercular evaluation of novel 5,6-diphenyl-1,2,4-triazine-piperazine derivatives targeting mycobacterial dihydrofolate reductase.
Journal: ADMET & DMPK
Published: June 03, 2025
Recent advances in piperazine derivatives as antibacterial agents: a comprehensive review (2020-2024).
Journal: Molecular diversity
Published: May 26, 2025
Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents.
Journal: Scientific reports
Published: December 17, 2024
Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer's therapy.
Journal: Bioorganic chemistry
Published: July 16, 2024
Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer's agents: design, synthesis and biological evaluation.
Journal: Molecular diversity
Published: March 14, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026